A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk

BACKGROUND: Angiotensin II receptor blockers (ARBs) is a well-tolerated class of antihypertensive agents, exhibiting effective antihypertensive and cardiovascular protective function. The objective of the study was to examine the efficacy and safety of Allisartan Isoproxil, a newly developed, select...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Li, Xiao-hui, Huang, Zhi-jun, Yang, Guo-ping, Zhang, Guo-gang, Zhao, Shui-ping, Guo, Ying, Lu, Shi-juan, Ma, Jian-lin, Meng, Fan-bo, Chen, Ping, Yuan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333341/
https://www.ncbi.nlm.nih.gov/pubmed/25693004
http://dx.doi.org/10.1371/journal.pone.0117560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333341/
https://www.ncbi.nlm.nih.gov/pubmed/25693004
http://dx.doi.org/10.1371/journal.pone.0117560

Ejemplares similares